These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24900612)

  • 1. Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.
    Haftchenary S; Luchman HA; Jouk AO; Veloso AJ; Page BD; Cheng XR; Dawson SS; Grinshtein N; Shahani VM; Kerman K; Kaplan DR; Griffin C; Aman AM; Al-Awar R; Weiss S; Gunning PT
    ACS Med Chem Lett; 2013 Nov; 4(11):1102-7. PubMed ID: 24900612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.
    Ouédraogo ZG; Müller-Barthélémy M; Kemeny JL; Dedieu V; Biau J; Khalil T; Raoelfils LI; Granzotto A; Pereira B; Beaudoin C; Guissou IP; Berger M; Morel L; Chautard E; Verrelle P
    Brain Pathol; 2016 Jan; 26(1):18-30. PubMed ID: 25736961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
    Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
    J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.
    Wang Y; Yang C; Sims MM; Sacher JR; Raje M; Deokar H; Yue P; Turkson J; Buolamwini JK; Pfeffer LM
    Cancer Lett; 2022 May; 533():215614. PubMed ID: 35245627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
    Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
    Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
    Assi HH; Paran C; VanderVeen N; Savakus J; Doherty R; Petruzzella E; Hoeschele JD; Appelman H; Raptis L; Mikkelsen T; Lowenstein PR; Castro MG
    J Pharmacol Exp Ther; 2014 Jun; 349(3):458-69. PubMed ID: 24696041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLUG Directs the Precursor State of Human Brain Tumor Stem Cells.
    Chesnelong C; Hao X; Cseh O; Wang AY; Luchman HA; Weiss S
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model.
    Kim BH; Lee H; Park CG; Jeong AJ; Lee SH; Noh KH; Park JB; Lee CG; Paek SH; Kim H; Ye SK
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway.
    Yuk N; Jung HJ
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
    Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
    Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
    Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
    Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
    Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells.
    Han D; Yu T; Dong N; Wang B; Sun F; Jiang D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):289. PubMed ID: 31277685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
    Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
    Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.